FDA joins Tox21 collaboration

The FDA has signed on with the Tox21 collaboration. The regulator joins the EPA, the National Institute of Environmental Health Sciences National Toxicology Program, and the National Institute of Health Chemical Genomics Center in developing models to predict how chemicals will affect human health and the environment. Release

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.